KR100757787B1 - 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체 - Google Patents

진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체 Download PDF

Info

Publication number
KR100757787B1
KR100757787B1 KR1020047017143A KR20047017143A KR100757787B1 KR 100757787 B1 KR100757787 B1 KR 100757787B1 KR 1020047017143 A KR1020047017143 A KR 1020047017143A KR 20047017143 A KR20047017143 A KR 20047017143A KR 100757787 B1 KR100757787 B1 KR 100757787B1
Authority
KR
South Korea
Prior art keywords
ethyl
compound
carboxylic acid
tetrazol
isoquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
KR1020047017143A
Other languages
English (en)
Korean (ko)
Other versions
KR20040102171A (ko
Inventor
폴 레슬리 언스타인
Original Assignee
일라이 릴리 앤드 캄파니
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일라이 릴리 앤드 캄파니 filed Critical 일라이 릴리 앤드 캄파니
Publication of KR20040102171A publication Critical patent/KR20040102171A/ko
Application granted granted Critical
Publication of KR100757787B1 publication Critical patent/KR100757787B1/ko
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020047017143A 2002-04-26 2003-04-14 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체 Expired - Fee Related KR100757787B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37612002P 2002-04-26 2002-04-26
US60/376,120 2002-04-26
PCT/US2003/010466 WO2003091243A1 (en) 2002-04-26 2003-04-14 Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics

Publications (2)

Publication Number Publication Date
KR20040102171A KR20040102171A (ko) 2004-12-03
KR100757787B1 true KR100757787B1 (ko) 2007-09-11

Family

ID=29270765

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020047017143A Expired - Fee Related KR100757787B1 (ko) 2002-04-26 2003-04-14 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체

Country Status (18)

Country Link
US (1) US7247644B2 (https=)
EP (1) EP1511741B1 (https=)
JP (2) JP2005529892A (https=)
KR (1) KR100757787B1 (https=)
CN (1) CN100436446C (https=)
AU (1) AU2003226277B2 (https=)
BR (1) BR0308911A (https=)
CA (1) CA2480026C (https=)
DK (1) DK1511741T3 (https=)
EA (1) EA009526B1 (https=)
ES (1) ES2398225T3 (https=)
IL (1) IL164773A (https=)
MX (1) MXPA04009857A (https=)
NZ (1) NZ535245A (https=)
PT (1) PT1511741E (https=)
SI (1) SI1511741T1 (https=)
WO (1) WO2003091243A1 (https=)
ZA (1) ZA200409552B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100757787B1 (ko) * 2002-04-26 2007-09-11 일라이 릴리 앤드 캄파니 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체
US8603980B2 (en) 2007-01-16 2013-12-10 The Johns Hopkins University Glutamate receptor antagonists and methods of use
MX2022016223A (es) 2020-07-02 2023-02-23 Sea Pharmaceuticals Llc Composiciones farmaceuticas de acido 6-(2-(2h-tetrazol-5-il)etil)- 6-fluorodecahidroisoquinolina-3-carboxilico y derivados de ester del mismo.
WO2022261287A1 (en) * 2021-06-09 2022-12-15 Proniras Corporation Methods of treating nerve agent-induced seizures
WO2023130008A2 (en) * 2022-01-01 2023-07-06 Sea Pharmaceuticals Llc Pharmaceutical compositions of 6-(2-(2h-tetrazol-5-yl)ethyl)decahydroisoquinoline-3-carboxylic acid and derivatives thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK406686D0 (da) * 1986-08-26 1986-08-26 Hans Bundgaard Carboxylsyrederivater
US4902695A (en) * 1989-02-13 1990-02-20 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5284957A (en) * 1992-09-03 1994-02-08 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5356902A (en) 1992-11-06 1994-10-18 Eli Lilly And Company Decahydroisoquinoline compounds as excitatory amino acid receptor antagonists
US5446051A (en) 1994-05-31 1995-08-29 Eli Lilly And Company Aryl-spaced decahydroisoquinoline-3-carboxylic acids as excitatory amino acid receptor antagonists
US5767117A (en) 1994-11-18 1998-06-16 The General Hospital Corporation Method for treating vascular headaches
HUP0002030A3 (en) 1997-04-07 2002-01-28 Lilly Co Eli Use of glur5 receptorantagonists for the treatment of pain
EP1200073B1 (en) 1999-07-06 2007-01-10 Eli Lilly And Company SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
WO2001002367A2 (en) * 1999-07-06 2001-01-11 Eli Lilly And Company Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
AU2574801A (en) 1999-12-22 2001-07-03 Eli Lilly And Company Selective iGLUR5 receptor antagonists
WO2002053556A2 (en) 2001-01-05 2002-07-11 Eli Lilly And Company Pyrrolidinylmethyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
WO2003024453A1 (en) 2001-01-05 2003-03-27 Eli Lilly And Company Excitatory amino acid receptor antagonists
AU2002227020A1 (en) 2001-01-05 2002-07-16 Eli Lilly And Company Pyrrolidinylmethyl- and piperidinyl substituted decahydroisoquinolines as excitatory amino acid receptor antagonists
WO2003024934A2 (en) 2001-01-05 2003-03-27 Eli Lilly And Company Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1, 2, 3, 4, 4a, 5, 6, 7, 8, 8a-decahydro isoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
WO2003082856A1 (en) 2002-03-22 2003-10-09 Eli Lilly And Company Isoquinoline-3-carboxylic acid derivatives as excitatory amino acid receptor antagonists
KR100757787B1 (ko) * 2002-04-26 2007-09-11 일라이 릴리 앤드 캄파니 진통제로서의 데카히드로이소퀴놀린-3-카르복실산의 에스테르 유도체

Also Published As

Publication number Publication date
WO2003091243A8 (en) 2005-03-31
CN1649862A (zh) 2005-08-03
ZA200409552B (en) 2006-02-22
IL164773A (en) 2011-08-31
NZ535245A (en) 2007-11-30
PT1511741E (pt) 2013-02-05
JP2010235623A (ja) 2010-10-21
AU2003226277A1 (en) 2003-11-10
IL164773A0 (en) 2005-12-18
DK1511741T3 (da) 2013-01-21
KR20040102171A (ko) 2004-12-03
EA009526B1 (ru) 2008-02-28
CA2480026A1 (en) 2003-11-06
SI1511741T1 (sl) 2013-02-28
CA2480026C (en) 2011-06-07
WO2003091243A1 (en) 2003-11-06
US7247644B2 (en) 2007-07-24
EP1511741B1 (en) 2012-12-26
MXPA04009857A (es) 2004-12-07
AU2003226277B2 (en) 2009-03-26
US20050256155A1 (en) 2005-11-17
EP1511741A1 (en) 2005-03-09
JP2005529892A (ja) 2005-10-06
CN100436446C (zh) 2008-11-26
BR0308911A (pt) 2005-01-04
ES2398225T3 (es) 2013-03-14
EA200401432A1 (ru) 2005-04-28

Similar Documents

Publication Publication Date Title
CA2748251C (en) Bicyclic heterocyclic compound for use as a sensory neuron specific sodium channel inhibitor
EP1200073B1 (en) SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
KR101952457B1 (ko) [3-(1-(1h-이미다졸-4-일)에틸)-2-메틸페닐] 메탄올의 에스테르 프로드러그
JPH02134377A (ja) ビペリジニルベンズイミダゾール類
JPH02300167A (ja) 鎮痛剤として用いられるｎ―フエニル―ｎ―（４―ピペリジニル）アミド
EP1208087B1 (en) Diester prodrugs of a decahydroisoquinoline-3-carboxylic acid
JP2010235623A (ja) 鎮痛剤としてのデカヒドロイソキノリン−３−カルボン酸のエステルプロドラッグ
CA3099775A1 (en) Process for making 1-(acyloxy)-alkyl-carabmate drug conjugates of naproxen and pregabalin
JP2008179650A (ja) 興奮性アミノ酸レセプターアンタゴニストを含有する医薬組成物
US6924294B2 (en) Excitatory amino acid receptor antagonists
US7205313B2 (en) Excitatory amino acid receptor antagonists
EP1351689A2 (en) Derivatives of the (3s, 4ar, 6s, 8ar) 6-phenylamino-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid as excitatory amino acid receptor antagonists for the treatment of neurological disorders and neurodegenerative diseases
JP2004522804A5 (https=)
JP3007675B2 (ja) 新規なインドール誘導体
US20040082606A1 (en) Excitatory amino acid receptor antagonists
NZ525821A (en) Excitatory amino acid receptor antagonists used in neurological disorders and neurodegenerative diseases
AU2002227021A1 (en) Excitatory amino acid receptor antagonists

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

FPAY Annual fee payment

Payment date: 20110830

Year of fee payment: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

FPAY Annual fee payment

Payment date: 20120830

Year of fee payment: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20130906

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20130906